Products

Have an Emergency?

For urgent assistance, please contact emergency response services.

Call: 911

Product Questions?

Questions, comments or concerns about Rising Pharmaceuticals products? Contact one of our trusted professionals today.

Call (800) 521-5340
info@risingpharma.com

Compare Products

Compares to the labeled active ingredients in Reference Brand. The trademark or tradename referenced is NOT registered, owned or licensed by Rising Pharmaceuticals, Inc. or its affiliates.

An activity supressor of key areas in central nervous system, this drug is indicated for symptomatic relief from anxiety and tension associated with psychoneurosis, pruritis due to allergic reactions, and an adjunct to sedatives.

Hydroxyzine Pamoate Capsules, USP Hydroxyzine Pamoate Capsules, USP Hydroxyzine Pamoate Capsules, USP Hydroxyzine Pamoate Capsules, USP

Hydroxyzine Pamoate Capsules, USP

Compare to: Vistaril® Capsules*
Strength: 25mg | 50mg
* Vistaril® is a registered trademark of Pfizer, Inc.
This information has been designed as a quick reference. It is intended as a reference source only and not for prescribing or dispensing product. The appropriate approved prescribing information should be consulted. Images viewed herein may appear different than they do when viewing them live because of computer and/or photographic distortion. In addition, over time, some images and information for a particular product may change. For the most up-to-date product information, please contact your pharmacist or physician.

For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested.

Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus.

As a sedative when used as premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol®) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent.

The effectiveness of hydroxyzine as an antianxiety agent for long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically the usefulness of the drug for the individual patient.